▲ Bullish
FED
Fed’s Powell says rate cut ‘on the table’ as soon as September
The Federal Reserve's indication that a rate cut may be on the horizon as early as September could lead to increased investor confidence and a boost in US equity prices. This potential shift in monetary policy could also lead to increased borrowing and spending, further stimulating economic growth.
▲ Bullish
FED
Powell says labor market not a source of significant inflation pressure
The Federal Reserve's assessment that the labor market is not a significant source of inflation pressure could lead to a decrease in interest rates, which would have a positive impact on US equity prices. This could also lead to increased consumer spending and economic growth.
▲ Bullish
MACRO
Swiss National Bank cuts interest rates by a half point to 0.5%
The Swiss National Bank's decision to cut interest rates could lead to increased investment in US equities as investors seek higher returns. This could also lead to increased economic growth and a boost in global trade.
▲ Bullish
MACRO
Dollar jumps 0.5% to 0.8890 francs
The strengthening of the US dollar could lead to increased exports and economic growth, which would have a positive impact on US equity prices. However, a strong dollar could also make US goods more expensive for foreign buyers, potentially decreasing demand.
▲ Bullish
MACRO
Germany flash manufacturing PMI rises to 4-month high of 43.2
The increase in Germany's manufacturing PMI could indicate a potential turnaround in the global economy, which would have a positive impact on US equity prices. This could also lead to increased investment and economic growth.
▲ Bullish
TECH
Morgan Stanley resets PANW stock price target on demand trends
Morgan Stanley's decision to reset the stock price target for PANW could indicate a potential increase in demand for the company's products, which would have a positive impact on US equity prices. This could also lead to increased investment and economic growth.
▲ Bullish
HEALTHCARE
Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic Partnership
The strategic partnership between Tempus AI and Bristol Myers could lead to increased investment and innovation in the healthcare sector, which would have a positive impact on US equity prices. This could also lead to the development of new treatments and therapies.
▲ Bullish
HEALTHCARE
CRISPR Therapeutics AG (CRSP) Reports Q1 2026 Results
CRISPR Therapeutics' Q1 2026 results could indicate a potential increase in demand for the company's products, which would have a positive impact on US equity prices. This could also lead to increased investment and innovation in the healthcare sector.